Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3,100	2,966	3,777	5,447	10,044	1,673
Market Cap Growth	-9.32%	-21.48%	-30.66%	-45.77%	500.43%	-14.73%
Enterprise Value	2,214	1,983	2,494	4,640	8,639	1,326
PE Ratio	-	-20.42	-11.59	-18.74	141.20	-8.46
PS Ratio	10.50	8.97	34.82	111.93	29.92	62.71
PB Ratio	2.13	2.88	3.62	5.66	8.73	4.24
P/FCF Ratio	-6.72	-8.00	-14.39	-24.77	24.32	-9.87
P/OCF Ratio	-6.92	-8.28	-15.43	-25.77	24.14	-11.04
EV/Sales Ratio	7.50	6.00	22.99	95.35	25.74	49.72
EV/EBITDA Ratio	-15.34	-15.44	-7.90	-16.42	107.33	-6.98
EV/EBIT Ratio	-14.35	-13.66	-7.65	-15.94	120.05	-6.70
EV/FCF Ratio	-4.63	-5.35	-9.50	-21.10	20.91	-7.83
Debt / Equity Ratio	0.03	0.05	0.05	0.06	0.06	0.17
Debt / EBITDA Ratio	-0.39	-0.41	-0.17	-0.21	0.80	-0.36
Debt / FCF Ratio	-0.12	-0.14	-0.20	-0.27	0.16	-0.41
Quick Ratio	11.34	13.27	3.67	2.29	20.50	9.16
Current Ratio	11.79	13.65	3.77	2.37	20.86	9.48
Asset Turnover	0.22	0.26	0.08	0.03	0.33	0.04
Return on Equity (ROE)	-11.50%	-13.50%	-35.70%	-28.00%	9.20%	-43.30%
Return on Assets (ROA)	-10.40%	-11.40%	-24.60%	-19.70%	7.10%	-32.00%
Return on Capital (ROIC)	-12.86%	-18.16%	-31.11%	-28.97%	5.10%	-45.97%
Earnings Yield	-4.43%	-4.90%	-8.63%	-5.33%	0.71%	-11.81%
FCF Yield	-13.71%	-12.51%	-6.95%	-4.04%	4.11%	-10.13%
Buyback Yield / Dilution	-9.43%	-9.43%	-3.30%	-1.34%	-25.43%	-3.22%
Total Shareholder Return	-9.43%	-9.43%	-3.30%	-1.34%	-25.43%	-3.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).